The finnish diabetes risk score is associated with insulin resistance and progression towards type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 3, 2009, Pages 920-926

  Schwarz, Peter E H ^a   Li, Jiang ^a   Reimann, Manja ^a   Schutte, Alta E ^b   Bergmann, Antje ^a   Hanefeld, Markolf ^c   Bornstein, Stefan R ^a   Schulze, Jan ^a   Tuomilehto, Jaakko ^d,f   Lindström, Jaana ^d,e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NORTH WEST UNIVERSITY   (South Africa)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 62349125897     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2427     Document Type: Article

References (47)

1. Zimmet P, Alberti KG, Shaw J 2001 Global and societal implications of the diabetes epidemic. Nature 414:782-787
2. Haffner SM 2002 Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. Int J Clin Pract Suppl 33-39
3. DECODE Study Group 2003 Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26:61-69
4. Nestle M 2005 Preventing childhood diabetes: the need for public health intervention. Am J Public Health 95:1497-1499
5. Schwarz PE, Govindarajalu S, Towers W, Schwanebeck U, Fischer S, Vasseur F, Bornstein SR, Schulze J 2006 Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm Metab Res 38:447-451
6. Trajkovski M, Mziaut H, Schwarz PE, Solimena M 2006 Genes of type 2 diabetes in β cells. Endocrinol Metab Clin North Am 35:357-369
7. Haffner SM, Miettinen H, Gaskill SP, Stern MP 1995 Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44:1386-1391
8. Johanson EH, Jansson PA, Lonn L,Matsuzawa Y, Funahashi T,TaskinenMR, Smith U, Axelsen M 2003 Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes. J Clin Endocrinol Metab 88:4232-4238
9. Schwarz PE, Bomstein SR 2006 Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res 38:359
10. 1998 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ [Erratum (1999) 318:29] 317:703-713
11. Schwarz PE, Gruhl U, Schuppenies A, Schulze J, Bomstein SR 2007 [Prevention of diabetes mellitus: the future of German diabetology]. Hamostaseologie 27:13-21 (German)
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
13. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ 1999 Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213-219
14. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K 2004 A Danish diabetes risk score for targeted screening: the lnter99 study. Diabetes Care 27:727-733
15. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ 2000 Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164-171
16. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE 1995 Anew and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382-387
17. Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E 2005 Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 28:404-408
18. Mohan V, Deepa R, Deepa M, Somannavar S, Datta M 2005 A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India 53:759-763
19. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ 1997 Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491-496
20. Stern MP, Williams K, Hafmer SM 2002 Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575-581
21. Schwarz P 2005 [Targeted diabetes prevention in high risk groups: pro]. Dtsch Med Wochenschr 130:1103 (German)
22. Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, OksaH, Korpi-Hyovalti E, Tuomilehto J, FIN-D2D Study Group 2007 National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 66:101-112
23. Schwarz PE, Schwarz J, Schuppenies A, Bornstein SR, Schulze J 2007 Development of a diabetes prevention management program for clinical practice. Public Health Rep 122:258-263
24. Silventoinen K, Pankow J, Lindstrom J, Jousilahti P, Hu G, Tuomilehto J 2005 The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil 12:451-458
25. Lindstrom J, Tuomilehto J 2003 The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731
26. Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J 2005 Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vase Dis Res 2:67-72
27. Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE 2007 A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res 39:677-682
28. Hanefeld M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U 1991 Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM. Diabetes Care 14:308-317
29. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M 2002 Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 51:743-749
30. Schwarz PE, Towers GW, Fischer S, Govindarajalu S, Schulze J, Bornstein SR, Hanefeld M, Vasseur F 2006 Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 29:1645-1650
31. World Health Organization, Department of Noncommunicable Disease Surveillance 1999 Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance
32. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
33. Schuppenies A, Jacobey H, Bornstein S, Schwarz PEH 2006 FINDRISK-Development of a questionnaire to estimate the risk of diabetes. ERNAHRUNGS- UMSCHAU 53:386
34. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R 2003 Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26:3320-3325
35. Hwalla N, Shaker L, Torbay N, Azar ST, Habbal Z, Adra N 2005 Postprandial glycemic and insulinemic responses to high-carbohydrate vs high-protein meals in obese normoglycemic subjects with varied insulin sensitivity. Nutr Res 25:535-548
36. Silman AJ, Macfarlane GJ 2002 Epidemiological studies: a practical guide. 2nd ed. Cambridge, UK: Cambridge University Press
37. Hanley JA, McNeil BJ 1983 A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843
38. Ferrannini E 1998 Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477-490
39. Weyer C, Tataranni PA, Bogardus C, Pratley RE 2001 Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89-94
40. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, LachinJM, Walker EA, Nathan DM 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
41. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV 1997 Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
42. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
43. Schwarz PE, Peltonen M 2007 Prevention of type 2 diabetes - lessons we have learnt for implementation. Horm Metab Res 39:636-641
44. Simmons RK, Harding AH, Wareham NJ, Griffin SJ 2007 Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes? Diabet Med 24:830-835
45. Harding AH, Griffin SJ, Wareham NJ 2006 Population impact of strategies for identifying groups at high risk of type 2 diabetes. Prev Med 42:364-368
46. Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J, DE-PLAN project 2008 The European perspective of type 2 diabetes prevention: diabetes in Europe-prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 116:167-172
47. Schwarz PE, Gruhl U, Bornstein SR, Landgraf R, Hall M, Tuomilehto J 2007 The European perspective on diabetes prevention: development and Implementation of A European Guideline and training standards for diabetes prevention (IMAGE). Diab Vase Dis Res 4:353-357